Two months into Israel’s COVID vaccination drive, most comprehensive study yet shows level of effectiveness

The Pfizer coronavirus vaccine on average prevents 94 percent of symptomatic illness and 92 percent of serious illness, an analysis of the medical data from 1.2 million Israeli patients shows